Maintenance therapy in the myeloproliferative disorders: the current options

Medicine and Dentistry

• Essential Thrombocythaemia 83%
• Recombinant Interferon 50%
• Patient 50%
• Interferon 33%
• Combination Therapy 33%
• Maintenance Therapy 33%
• Myeloproliferative Disorder 33%
• Toxicity 16%
• Platelet 16%
• Chronic Myelogenous Leukemia 16%
• Interferon Alfa 16%
• Anesthesia Induction 16%
• Polycythemia vera 16%
• Myelofibrosis 16%
• Inpatient 16%

INIS

• interferon 100%
• patients 66%
• therapy 66%
• maintenance 66%
• data 16%
• control 16%
• toxicity 16%
• induction 16%
• leukemia 16%
• polycythemia 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Thrombocythemia 83%
• Recombinant Interferon 50%
• Interferon 33%
• Myeloproliferative Disorder 33%
• Toxicity 16%
• Chronic Myeloid Leukemia 16%
• Alpha Interferon 16%
• Polycythemia vera 16%
• Myelofibrosis 16%